MedTrace Logo

Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma

NCT01504646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-10-23

No results posted yet for this study

Summary

The primary aim of this study will be to evaluate the effects of Lyprinol® supplementation on airway inflammation and the bronchoconstrictor response to dry air hyperpnea in individuals with asthma. The investigators hypothesize that Lyprinol® supplementation, compared to placebo, will significantly attenuate airway inflammation and hyperpnea-induced bronchoconstriction in asthmatic individuals.

Conditions

  • Asthma
  • Exercise-Induced Bronchoconstriction

Interventions

DIETARY_SUPPLEMENT

Lyprinol

8 capsules (1 capsule=50mg n-PUFA, 100mg olive oil) per day for 3 weeks

DIETARY_SUPPLEMENT

Placebo (Olive Oil)

8 capsules (1 capsule = 100mg olive oil) per day for 3 weeks

Sponsors & Collaborators

  • Pharmalink

    collaborator INDUSTRY

  • Indiana University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01504646 on ClinicalTrials.gov